Kabra Drugs received a Letter of Intent from the Chhattisgarh government for a ₹200 crore pharmaceutical facility at Nava Raipur Pharma Park. The project aims to boost production capacity and create jobs.

Kabra Drugs Plans ₹200 Crore Pharma Facility in Chhattisgarh

Kabra Drugs Limited has received a Letter of Intent (LOI) from the Government of Chhattisgarh to establish a new pharmaceutical manufacturing facility. The proposed investment is ₹200 crore.

Reader Takeaway: Growth commitment with state support; subject to final approvals.

What just happened

Kabra Drugs announced it received a Letter of Intent (LOI) from the Government of Chhattisgarh on June 12, 2026. The LOI is for setting up a new pharmaceutical manufacturing facility at the Nava Raipur Pharma Park.

Why this matters

This ₹200 crore investment signifies a major expansion for Kabra Drugs, aiming to significantly increase its production capacity. The project is expected to create approximately 250 direct and indirect employment opportunities in the region and positions the company to capture new market opportunities.

The backstory

Kabra Drugs is focused on strengthening its operational capabilities. This expansion aligns with the company's long-term growth strategy to build a robust, future-ready pharmaceutical platform.

What changes now

The company will now work towards finalizing definitive agreements and securing all necessary statutory and regulatory approvals for the project. This LOI is a preliminary step in the planned expansion.

Risks to watch

The primary watch point is that the project is still in the LOI stage. The investment is contingent upon the successful execution of final agreements and obtaining all required statutory and regulatory clearances.

Context metrics (time-bound)

• Proposed Investment: ₹200 crore
• Project Location: Nava Raipur Pharma Park, Chhattisgarh
• Employment Generation: ~250 direct and indirect opportunities
• LOI Receipt Date: June 12, 2026

What to track next

Investors should monitor the progress of Kabra Drugs in converting the LOI into formal agreements and obtaining the necessary regulatory approvals. The timeline for project implementation will be a key indicator.